Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
clinical trials
Biotech
Bain-backed Angitia drops lead spinal fusion candidate
The musculoskeletal outfit has scrapped AGA111, terminating a phase 3 study of the recombinant protein in patients undergoing spinal fusion surgery.
Darren Incorvaia
Jun 30, 2026 4:56pm
HHS unveils plan to speed up ph. 1 trials by 6 to 12 months
Jun 22, 2026 12:10pm
How RA Capital is offering ‘Chinese clinical expertise in a box’
Jun 5, 2026 8:19am
ASCO, Ryght AI team up for breast cancer trial site selection
Jun 1, 2026 2:00pm
Clinical trial flaws ‘being scaled, not solved’ by AI: report
May 19, 2026 10:48am
Icon opens Texas research unit and new satellite clinics
May 13, 2026 1:52pm
